EGF has been identified as a factor associated with lung growth and respiratory diseases since its discovery in the early 1960s; however, there is a lack of knowledge of whether EGF in amniotic fluid may be a predictive biomarker of respiratory outcomes in preterm neonates. Here, EGF is linked to respiratory system disorder.